The effects of antirheumatic drugs on reproductive function.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Reproductive Toxicology

• Publication date

  1997-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0890-6238(97)89175-7PMID 9241677
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Abnormal Semen Quality and Low Serum Testosterone in Men with Inflammatory Bowel Disease Treated for a Long Time with Sulfasalazine *

  2009cited by this paper
• Autometallographic demonstration of gold in human fetal liver and placenta

  2004cited by this paper
• Neonatal renal dysfunction and intrauterine exposure to prostaglandin synthesis inhibitors

  2004cited by this paper
• The effect of d-penicillamine of the skeletal development of rat foetuses

  2004cited by this paper
• Chromosomes in patients treated with Imuran

  2004cited by this paper
• Minocycline in rheumatoid arthritis.

  1997cited by this paper
• Maternal serum thromboxane B2 reduction versus pregnancy outcome in a low-dose aspirin trial.

  1995cited by this paper
• Fetal echocardiography during indomethacin treatment

  1995cited by this paper
• Reproductive function and outcome of pregnancy after liver transplantation in women.

  1995cited by this paper
• Antiphospholipid antibodies and antiphospholipid syndrome

  1995cited by this paper
• Pregnancy in renal transplant recipients: the Christchurch experience.

  1995cited by this paper
• Fetal Cardiac Function and Ductus Arteriosus During Indomethacin and Sulindac Therapy for Threatened Preterm Labor: A Randomized Study

  1995cited by this paper
• Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes.

  1995cited by this paper
• Teratogenic potential of corticosteroids in humans.

  1995cited by this paper
• Outcomes of 500 pregnancies in 335 female kidney, liver, and heart transplant recipients.

  1995cited by this paper
• Variables affecting birthweight and graft survival in 197 pregnancies in cyclosporine-treated female kidney transplant recipients.

  1995cited by this paper
• Long-term effects of prenatal indomethacin administration on the pulmonary circulation in rats.

  1995cited by this paper
• Effects of immunosuppressive drugs during pregnancy.

  1995cited by this paper
• Perinatal outcomes in the pregnancies of asthmatic women: a prospective controlled analysis.

  1995cited by this paper
• Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes: NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes

  1995cited by this paper
• Minocycline in Rheumatoid Arthritis: A 48-Week, Double-Blind, Placebo-Controlled Trial

  1995cited by this paper
• Thalidomide as salvage therapy for chronic graft-versus-host disease.

  1995cited by this paper
• Patent ductus arteriosus. Clinical relevance of prostaglandins and prostaglandin inhibitors in PDA pathophysiology and treatment.

  1995cited by this paper
• Persistent anuria, neonatal death, and renal microcystic lesions after prenatal exposure to indomethacin.

  1994cited by this paper
• Renal failure in the neonate associated with in utero exposure to non-steroidal anti-inflammatory agents

  1994cited by this paper
• Thalidomide in the management of chronic graft-versus-host disease in children following bone marrow transplantation.

  1994cited by this paper
• Systemic lupus erythematosus and pregnancy.

  1994cited by this paper
• Outcomes of pregnancy and the management of immunosuppressive agents to minimize fetal risks in organ transplant patients.

  1994cited by this paper
• Pediatric systemic lupus erythematosus and neonatal lupus.

  1994cited by this paper
• Tenidap modulates cytoplasmic pH and inhibits anion transport in vitro. I. Mechanism and evidence of functional significance.

  1994cited by this paper
• The Contribution of Environmental Teratogens to Embryonic and Fetal Loss

  1994cited by this paper
• Renal impairment in very low birthweight infants following antenatal indomethacin administration

  1994cited by this paper
• Single-Dose Systemic Methotrexate for the Treatment of Persistent Ectopic Pregnancy After Conservative Surgery

  1994cited by this paper
• Single-dose systemic methotrexate for the treatment of persistent ectopic pregnancy after conservative surgery.

  1994cited by this paper
• Isolated Small Bowel Perforation Following Intrauterine Treatment with Indomethacin

  1994cited by this paper
• Neonatal lupus syndromes.

  1994cited by this paper
• Pregnancy following renal transplantation.

  1994cited by this paper
• Pregnancy outcome in renal allograft recipients in Nor

  1994cited by this paper
• Tocolysis with indomethacin increases the incidence of necrotizing enterocolitis in the low-birth-weight neonate.

  1994cited by this paper
• Outcomes of pregnancy and the management of immunosuppressive agents to minimize fetal risks in organ transplant patients.

  1994cited by this paper
• Tenidap modulates cytoplasmic pH and inhibits anion transport in vitro. II. Inhibition of IL-1 beta production from ATP-treated monocytes and macrophages.

  1994cited by this paper
• National transplantation Pregnancy Registry--outcomes of 154 pregnancies in cyclosporine-treated female kidney transplant recipients.

  1994cited by this paper
• A review of randomized controlled trials of routine antimalarial drug prophylaxis during pregnancy in endemic malarious areas.

  1994cited by this paper
• Methotrexate exposure prior to and during pregnancy.

  1994cited by this paper
• Increased incidence of bronchopulmonary dysplasia after antenatal administration of indomethacin to prevent preterm labor.

  1994cited by this paper
• Spermatozoal abnormalities and male infertility in the rat following sulfasalazine treatment.

  1994cited by this paper
• Expression and relationships of seven public idiotypes of DNA-binding autoantibodies on monoclonal antibodies and serum immunoglobulins.

  1993cited by this paper
• Pregnancy outcome in women with systemic lupus erythematosus treated with immunosuppressive drugs.

  1993cited by this paper
• Acute Maternal Renal Insufficiency in Premature Labor Treated with Indomethacin

  1993cited by this paper
• An investigation into the effects of chloroquine on fertility of male rats.

  1993cited by this paper
• Maternal renal impairment after indomethacin tocolysis.

  1993cited by this paper
• Antimalarial drugs, pregnancy and lactation.

  1993cited by this paper
• Teratogenicity of cyclophosphamide in New Zealand white rabbits.

  1993cited by this paper
• The optimal use of cyclosporin A in rheumatoid arthritis: efficacy and outcome measures including quality of life.

  1993cited by this paper
• Low-dose aspirin therapy to prevent preeclampsia.

  1993cited by this paper
• Glucocorticoid Therapy for Immune-Mediated Diseases: Basic and Clinical Correlates

  1993cited by this paper
• Prenatal maternal indomethacin use resulting in prolonged neonatal renal insufficiency.

  1993cited by this paper
• Prenatal maternal indomethacin use resulting in prolonged neonatal renal insufficiency.

  1993cited by this paper
• Intravenous immunoglobulin treatment of Dregnant patients with recurrent pregnancy osses associated with antiphospholipid antibodies

  1993cited by this paper
• Teratogenicity and carcinogenicity in a twin exposed in utero to cyclophosphamide.

  1993cited by this paper
• Long-term nephrotoxicity after exposure to cyclosporine in utero.

  1993cited by this paper
• Prostaglandin synthetase inhibitors in pregnancy.

  1993cited by this paper
• National Transplantation Pregnancy Registry: analysis of pregnancy outcomes of female kidney recipients with relation to time interval from transplant to conception.

  1993cited by this paper
• Neonatal complications after the administration of indomethacin for preterm labor

  1993cited by this paper
• Pregnancy and kidney transplantation: clinical problems and experience.

  1993cited by this paper
• The Effect of Gestational Age and Fetal Indomethacin Levels on the Incidence of Constriction of the Fetal Ductus Arteriosus

  1993cited by this paper
• Immunological responses in an infant after cyclosporine A exposure during pregnancy

  1993cited by this paper
• Pregnancy and kidney transplantation: Clinical problems and experience

  1993cited by this paper
• Expression and Relationships of Seven Public Idiotypes of DNA-Binding Autoantibodies on Monoclonal Antibodies and Serum Immunoglobulins:

  1993cited by this paper
• Immunosuppressive therapy, management, and outcome of heart transplant recipients during pregnancy.

  1993cited by this paper
• Renal failure in two preterm infants: toxic effect of prenatal maternal indomethacin treatment?

  1993cited by this paper
• Thalidomide for systemic lupus erythematosus.

  1992cited by this paper
• Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment.

  1992cited by this paper
• THE OUTCOME OF PREGNANCY FOLLOWING RENAL TRANSPLANTATION—THE EXPERIENCE OF A SINGLE CENTER

  1992cited by this paper
• Manipulating the immune system with immune globulin.

  1992cited by this paper
• Effect of chloroquine chemoprophylaxis during pregnancy on birth weight: results of a randomized trial.

  1992cited by this paper
• An aspirin a day to prevent prematurity.

  1992cited by this paper
• Increased postimplantation loss and malformations among the F2 progeny of male rats chronically treated with cyclophosphamide.

  1992cited by this paper
• NSAIDs: Maternal and Fetal Considerations

  1992cited by this paper
• Thalidomide in Human Immunodeficiency Virus (HIV) Patients

  1992cited by this paper
• Oligohydramnios induced by maternal indomethacin therapy.

  1992cited by this paper
• Treatment With Immunosuppressive and Disease Modifying Drugs During Pregnancy and Lactation

  1992cited by this paper
• Cyclosporine in rheumatoid arthritis.

  1992cited by this paper
• Glucocorticoid Therapy for Rheumatic Diseases: Maternal, Fetal, and Breast‐Feeding Considerations

  1992cited by this paper
• [Teratologic studies of methyl 5-aminosalicylate and salicylazopyridine].

  1992cited by this paper
• The mechanism of action of cyclosporin A and FK506.

  1992cited by this paper
• The Effect of Cyclophosphamide Pulses on Fertility in Patients With Lupus Nephritis

  1992cited by this paper
• Immunosuppressive drug therapy for rheumatic disease.

  1991cited by this paper
• EVIDENCE THAT CYCLOSPORINE TREATMENT DURING PREGNANCY PREDISPOSES OFFSPRING TO DEVELOP AUTOANTIBODIES

  1991cited by this paper
• Gonadal protection and fecundity rates in cyclophosphamide-treated rats.

  1991cited by this paper
• The effects of indomethacin and a beta-sympathomimetic agent on the fetal ductus arteriosus during treatment of premature labor: a randomized double-blind study.

  1991cited by this paper
• Transfer of aspirin across the perfused human placental cotyledon.

  1991cited by this paper
• Long-Term Indomethacin Therapy Decreases Fetal Urine Output and Results in Oligohydramnios

  1991cited by this paper
• Pregnancy Outcome Following First Trimester Exposure to Chloroquine

  1991cited by this paper
• Pregnancy outcome in renal allograft recipients: influence of ciclosporin A.

  1991cited by this paper
• Male fertility in cyclosporine-treated renal transplant patients.

  1991cited by this paper
• THE EFFECT OF TWO NEW IMMUNOSUPPRESSIVE AGENTS, FK506 AND DIDEMNIN B, IN MURINE PREGNANCY

  1991cited by this paper
• Safety of azathioprine in pregnancy in inflammatory bowel disease.

  1990cited by this paper
• Safety and Efficacy of Long-Term Tocolysis with Indomethacin

  1990cited by this paper
• Prenatal Administration of Indomethacin as a Tocolytic Agent: Effect on Neonatal Renal Function

  1990cited by this paper

• Pregnancy outcome following in utero exposure to azathioprine: A French comparative observational study.

  2017cites this paper
• Pharmacotherapy of Rheumatic Diseases in Pregnancy

  2008cites this paper
• 2.1 – Analgesics and anti-inflammatory drugs

  2007cites this paper
• Prenatal effects of DuP-697-the irreversible, highly selective cyclooxygenase-2 inhibitor.

  2003cites this paper
• Teratogen update: azathioprine and 6-mercaptopurine.

  2002cites this paper
• Cox-2-specific inhibitors: definition of a new therapeutic concept.

  2001cites this paper